Driving innovation in smart medical devices at HLTH Europe 2026

HLTH Europe, which will be held in Amsterdam this year, has established itself as the reference meeting point for the transformation of the healthcare sector. It brings together more than 5,000 leaders and innovators, including healthcare providers, industry, start-ups and investors, with the aim of driving new technology solutions and healthcare models.

Accelerating healthcare transformation with smart medical devices

TECNALIA will showcase its value proposal in the field of smart medical devices, aimed at accompanying companies throughout the innovation cycle, from conceptualisation to market launch.

• The solutions developed by TECNALIA integrate advanced technologies, such as sensoring, connectivity, artificial intelligence and data analysis, in order to improve clinical outcomes and the efficiency of the healthcare system.
• This approach comprehensively addresses the entire patient pathway, from prevention and diagnosis to treatment and rehabilitation, contributing to more personalised, predictive and efficient healthcare.

From technological development to real market impact

One of the main challenges faced by the healthtech sector is transforming innovation into real impact. TECNALIA works on this critical point, supporting companies in:

• Design and development of smart medical devices
• Prototyping, validation and user trials
• Integration of artificial intelligence in secure environments
• Regulatory compliance and certification (MDR/IVDR)
• Industrial scaling-up and market transfer

Thanks to this end-to-end approach, TECNALIA helps to reduce the time and risks associated with the development of new products, accelerating their adoption in real clinical environments.

Innovation in key medical technologies

At HLTH Europe, TECNALIA will highlight some of its most relevant lines of innovation:

• Medical robotics and advanced surgery, with new automation and precision capabilities.
• 3D bio-printing and regenerative medicine for advanced therapies.
• Neuromodulation systems and non-invasive technologies.
• Predictive health modelling and AI-based diagnostics.
• Connected devices and remote patient monitoring.

These technologies address the sector's main challenges, such as the need to optimise resources, improve the quality of care and move towards more sustainable care models.

Technological partner for the healthtech industry

By attending HLTH Europe 2026, TECNALIA reinforces its position as a benchmark technological partner for the medical device and digital health industry, helping to accelerate the market launch of innovative solutions that improve people's lives.

Participation in this event will also be an opportunity to showcase some of the European projects that the Health Team is working on: 6SAVA or Bio4 Campus, Europe’s largest Bioeconomy Hub of the future.